Feature

Gottlieb leaves mixed legacy on drug prices, opioids, tobacco use

March 6, 2019
As a former adviser to several federal entities, FDA Commissioner Scott Gottlieb, MD was familiar with public service before he assumed his current…
FDA News

Gottlieb to step down as FDA commissioner

March 5, 2019
FDA Commissioner Scott Gottlieb, MD, announced his resignation effective 1 month from Tuesday, March 5, according to an HHS press release. The HHS…

AMA files suit to block Trump Administration’s Title X rule

March 5, 2019
Today, the AMA, along with the Oregon Medical Association and Planned Parenthood Federation of America, filed a lawsuit to block the Trump…

Drug companies grilled on pricing in Senate hearing

February 26, 2019
Representatives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Pfizer and Sanofi voiced support for drug rebate…

Doctors concerned, lawsuits threatened, after HHS issues final Title X rule

February 25, 2019
On Friday, HHS issued its final rule regarding the Title X family planning program, with the agency saying its changes “make notable…

Health care organizations aim to align SUD treatment records, HIPAA

February 21, 2019
The Partnership to Amend 42 CFR Part 2 — which encompasses more than 50 health care organizations — continues its efforts to ensure…

Congress introduces bill to protect living organ donors

February 15, 2019
Members of the U.S. House and Senate from New York, Washington state and Arkansas have introduced a bill in Congress to require employers to…

Renal Physicians Association voices concern about impact of Part D changes for transplant patients

February 13, 2019
The Renal Physicians Association has joined the National Kidney Foundation in voicing concern about how changes to the Medicare Part D drug benefit…

Trump announces 10-year plan to end HIV epidemic in US

February 6, 2019
During his second State of the Union address on Tuesday night, President Donald J. Trump asked for a bipartisan commitment to end the HIV epidemic…

Trump’s drug-pricing proposal a step forward, but may not have significant impact

February 6, 2019
The Trump Administration proposed a new rule last week to lower prices of prescription drugs and out-of-pocket costs by encouraging manufacturers to…